Predicting peptide binding affinities to MHC molecules using a modified semi-empirical scoring function

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Liao, Webber W P ^a   Arthur, Jonathan W ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN'S MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; HLA DR15 ANTIGEN; HLA DR4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; HLA A2 ANTIGEN; HLA DR ANTIGEN; HLA-DR15 ANTIGEN; PEPTIDE;

ACCURACY; ALLELE; ARTICLE; BINDING AFFINITY; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION COEFFICIENT; CRYSTAL STRUCTURE; FRESNO SEMI EMPIRICAL SCORING SYSTEM; PREDICTION; PROTEIN BINDING; SCORING SYSTEM; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; ALGORITHM; CHEMISTRY; GENETICS; HUMAN; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; METHODOLOGY; MULTIPLE SCLEROSIS; PROTEIN CONFORMATION; REFERENCE VALUE; REGRESSION ANALYSIS; X RAY CRYSTALLOGRAPHY;

ALGORITHMS; ALLELES; CRYSTALLOGRAPHY, X-RAY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-A2 ANTIGEN; HLA-DR SEROLOGICAL SUBTYPES; HLA-DR1 ANTIGEN; HUMANS; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 80053066016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025055     Document Type: Article

References (61)

1. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, Jager PD, et al. (2005) Multiple sclerosis. Immunological Reviews 204: 208-231.
2. Westall FC, (2006) Molecular mimicry revisited: gut bacteria and multiple sclerosis. Journal of Clinical Microbiology 44: 2099-2104.
3. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, et al. (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. Journal of Experimental Medicine 204: 2899-2912.
4. Lang HLE, Jacobsen H, Ikemizu S, Andersson C, Harlos K, et al. (2002) A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nature Immunology 3: 940-943.
5. Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FCJ, et al. (2002) Autoimmunity due to molecular mimicry as a cause of neurological disease. Nature Medicine 8: 509-513.
6. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. The New England Journal Of Medicine 357: 851-862.
7. Nielsen M, Lundegaard C, Lund O, (2007) Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8: 238.
8. Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, et al. (2008) Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Research 4: 2.
9. Bordner AJ, Mittelmann HD, (2010) Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model. BMC Bioinformatics 11: 41.
10. Wang P, Sidney J, Kim Y, Sette A, Lund O, et al. (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11: 568.
11. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, et al. (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61: 1-13.
12. Lata S, Bhasin M, Raghava GPS, (2007) Application of machine learning techniques in predicting MHC binders. Methods in Molecular Biology 409: 201-215.
13. Lundegaard C, Lamberth K, Harndahl M, Buus S, Lund O, et al. (2008) NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11. Nucleic Acids Research 36: W509-W512.
14. Lundegaard C, Hoof I, Lund O, Nielsen M, (2010) State of the art and challenges in sequence based T-cell epitope prediction. Immunome Research 6 (Suppl 2): S3.
15. Hattotuwagama CK, Doytchinova IA, Flower DR, (2007) Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Methods in Molecular Biology 409: 227-245.
16. Li Z, Wu S, Chen Z, Ye N, Yang S, et al. (2007) Structural parameterization and functional prediction of antigenic polypeptome sequences with biological activity through quantitative sequence-activity models (QSAM) by molecular electronegativity edge-distance vector (VMED). Science in China Series C: Life Sciences 50: 706-716.
17. Dimitrov I, Garnev P, Flower DR, Doytchinova I, (2010) Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. European Journal of Medicinal Chemistry 45: 236-243.
18. Kumar N, Mohanty D, (2007) MODPROPEP: A program for knowledge-based modeling of protein-peptide complexes. Nucleic Acids Research 35: W549-W555.
19. Schiewe AJ, Haworth IS, (2007) Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design. Journal of Molecular Graphics and Modelling 26: 667-675.
20. Aldulaijan S, Platts JA, (2010) Theoretical prediction of a peptide binding to major histocompatibility complex II. Journal of Molecular Graphics and Modelling 29: 240-245.
21. Bordner AJ, (2010) Towards universal structure-based prediction of class II MHC epitopes for diverse allotypes. PLoS ONE 5: e14383.
22. Nielsen M, Lundegaard C, Worning P, Lauemøller SL, Lamberth K, et al. (2003) Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Science 12: 1007-1017.
23. Liao WW, Arthur JW, (2011) Predicting peptide binding to Major Histocompatibility Complex molecules. Autoimmunity Reviews in publication.
24. Rognan D, Lauemoller SL, Holm A, Buus S, Tschinke V, (1999) Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. Journal of Medicinal Chemistry 42: 4650-4658.
25. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, et al. (2007) MolProbity: All-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Research 35: W375-W383.
26. Krivov GG, Shapovalov MV Jr. RLD, (2009) Improved prediction of protein side-chain conformations with SCWRL4. Proteins 77: 778-795.
27. Borbulevych OY, Insaidoo FK, Baxter TK, Powell DJ, Johnson LA, et al. (2007) Structures of MART-1(26/27-35) peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition. Journal of Molecular Biology 372: 1123-1136.
28. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, et al. (2000) The Protein Data Bank Nucleic Acids Research 28: 235-242.
29. Madden DR, Garboczi DN, Wiley DC, (1993) The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75: 693-708.
30. Word JM, Lovell SC, Richardson JS, Richardson DC, (1999) Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain. Journal of Molecular Biology 285: 1735-1747.
31. Blythe MJ, Doytchinova IA, Flower DR, (2002) JenPep: A database of quantitative functional peptide data for immunology. Bioinformatics 18: 434-439.
32. McSparron H, Blythe MJ, Zygouri C, Doytchinova IA, Flower DR, (2003) JenPep: a novel computational information resource for immunobiology and vaccinology. Journal of Chemical Information and Computer Science 43: 1276-1287.
33. Altuvia Y, Schueler O, Margalit H, (1995) Ranking potential binding peptides to MHC molecules by a computational threading approach. Journal of Molecular Biology 249: 244-250.
34. Eldridge M, Murray CW, Auton TA, Paolini GV, Lee RP, (1997) Empirical scoring functions: I. the development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes. Journal of Computer-Aided Molecular Design 11: 425-445.
35. Honig B, Nicholls A, (1995) Classical electrostatics in biology and chemistry. Science 268: 1144-1149.
36. Rocchia W, Alexov E, Honig B, (2001) Extending the applicability of the nonlinear Poisson-Boltzmann equation: Multiple dielectric constants and multivalent Ions. Journal of Physical Chemistry B 105: 6507-6514.
37. Sitkoff D, Sharp KA, Honig B, (1994) Accurate calculation of hydration free energies using macroscopic solvent models. Journal of Physical Chemistry 98: 1978-1988.
38. R Development Core Team (2009) R: A language and environment for statistical computing Vienna, Austria R Foundation for Statistical Computing.
39. Mevik B-H, Wehrens R, (2007) The pls package: Principal component and partial least squares regression in R. Journal of Statistical Software 18: 1-24.
40. Texier C, Pouvelle S, Busson M, Herve M, Charron D, et al. (2000) HLA-DR restricted peptide candidates for bee venom immunotherapy. Journal of Immunology 164: 3177-3184.
41. Wucherpfennig KW, Sette A, Southwood S, Oseroff C, Matsui M, et al. (1994) Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. Journal of Experimental Medicine 179: 279-290.
42. van Elsas A, van der Burg SH, van der Minne CE, Borghi M, Mourer JS, et al. (1996) Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen. European Journal of Immunology 26: 1683-1689.
43. Wilson CC, McKinney D, Anders M, MaWhinney S, Forster J, et al. (2003) Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. Journal of Immunology 171: 5611-5623.
44. Dionne SO, Smith MH, Marincola FM, Lake DF, (2003) Functional characterization of CTL against gp100 altered peptide ligands. Cancer Immunology and Immunotherapy 52: 199-206.
45. Solache A, Morgan CL, Dodi AI, Morte C, Scott I, et al. (1999) Identification of three HLA-A*0201-restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus. Journal of Immunology 163: 5512-5518.
46. Zeng G, Li Y, El-Gamil M, Sidney J, Sette A, et al. (2002) Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design. Cancer Research 62: 3630-3635.
47. Gras S, Saulquin X, Reiser JB, Debeaupuis E, Echasserieau K, et al. (2009) Structural bases for the affinity-driven selection of a public TCR against a dominant human Cytomegalovirus epitope. Journal of Immunology 183: 430-437.
48. Celie PHN, Toebes M, Rodenko B, Ovaa H, Perrakis A, et al. (2009) UV-Induced ligand exchange in MHC class I protein crystals. Journal of the American Chemical Society 131: 12298-12304.
49. Borbulevych OY, Baxter TK, Yu ZY, Restifo NP, Baker BM, (2005) Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: Implications for vaccine design. Journal of Immunology 174: 4812-4820.
50. Webb AI, Dunstone MA, Chen WS, Aguilar MI, Chen QY, et al. (2004) Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the design of a novel immunogenic analogue. Journal of Biological Chemistry 279: 23438-23446.
51. Willcox BE, Thomas LM, Bjorkman PJ, (2003) Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nature Immunology 4: 913-919.
52. Stewart-Jones GB, McMichael AJ, Bell JI, Stuart DI, Jones EY, (2003) A structural basis for immunodominant human T cell receptor recognition. Nature Immunology 4: 657-663.
53. Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, et al. (1997) Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387: 630-634.
54. Bouvier M, Guo HC, Smith KJ, Wiley DC, (1998) Crystal structures of HLA-A*0201 complexed with antigenic peptides with either the amino- or carboxyl-terminal group substituted by a methyl group. Proteins 33: 97-106.
55. Chen JL, Stewart-Jones G, Bossi G, Lissin NM, Wooldridge L, et al. (2005) Structural and kinetic basis for heightened immunogenicity of T cell vaccines. Journal of Experimental Medicine 201: 1243-1255.
56. Sami M, Rizkallah PJ, Dunn S, Molloy P, Moysey R, et al. (2007) Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. Protein Engineering, Design & Selection 20: 397-403.
57. Dunn SM, Rizkallah PJ, Baston E, Mahon T, Cameron B, et al. (2006) Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity. Protein Science 15: 710-721.
58. Hennecke J, Carfi A, Wiley DC, (2000) Structure of a covalently stabilized complex of a human alpha beta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO Journal 19: 5611-5624.
59. Hennecke J, Wiley DC, (2002) Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, Influenza Hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. Journal of Experimental Medicine 195: 571-581.
60. Smith KJ, Pyrdol J, Gauthier L, Wiley DC, Wucherpfennig KW, (1998) Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. Journal of Experimental Medicine 188: 1511-1520.
61. Hahn M, Nicholson MJ, Pyrdol J, Wucherpfennig KW, (2005) Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nature Immunology 6: 490-496.